DANIEL LEVY, M.D.
Osteopathic Medicine at Mount Wayte Ave, Framingham, MA
License number
Massachusetts 49895
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
73 Mount Wayte Ave #2, Framingham, MA 01702
175 Woodward St, Newton, MA 02461
175 Woodward St, Newton, MA 02461
Phone
(508) 935-3458
Personal information
See more information about DANIEL LEVY at radaris.comName
Address
Phone
50 Revell Ave, Northampton, MA 01060
51 John St APT 204, Brookline, MA 02446
362 Memorial Dr, Cambridge, MA 02139
32 Summer St, Saugus, MA 01906
31 Anderson Dr, Randolph, MA 02368
Organization information
See more information about DANIEL LEVY at bizstanding.comDaniel Levy MD
73 Mt Wayte Ave, Framingham, MA 01702
Industry:
Internist
Phone:
(508) 935-3458 (Phone)
Daniel Levy
Professional information
See more information about DANIEL LEVY at trustoria.com
Dr. Daniel Levy, Newton Highlands MA - MD (Doctor of Medicine)
Dr. Daniel Levy, Newton Highlands MA - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
175 Woodward St, Newton Highlands 02461
(617) 332-5763 (Phone)
(617) 332-5763 (Phone)
Procedures:
Cardiac Myocardial Perfusion Imaging
Conditions:
Hyperlipidemia, Hypertension
Certifications:
Cardiovascular Disease, 1985, Internal Medicine, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Boston University School of Medicine
Graduated: 1980
U Hosp
Brigham and Womens Hospital
Boston University School of Medicine
Graduated: 1980
U Hosp
Brigham and Womens Hospital
Estrogen Receptor Gene Variation And Disease
Estrogen Receptor Gene Variation And Disease
US Patent:
2005015, Jul 14, 2005
Filed:
Nov 4, 2004
Appl. No.:
10/982726
Inventors:
David Housman - Newton MA, US
Daniel Levy - Newton MA, US
Michael Mendelsohn - Wellesley MA, US
Amanda Shearman - Somerville MA, US
Daniel Levy - Newton MA, US
Michael Mendelsohn - Wellesley MA, US
Amanda Shearman - Somerville MA, US
International Classification:
C12Q001/68, C12P019/34
US Classification:
435006000, 435091200
Abstract:
Methods for determining the presence of polymorphisms in estrogen receptor genes and assessing an individual's risk for developing a condition are provided herein.